1/29
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Porphyrins
Cyclic compounds that readily bind metal ions, usually ferrous (Fe2) or Ferric (Fe3) iron forming metalloporphyrin (a prosthetic group).
Structure of Heme prophyrin
One Fe2+ coordinated in the center of the tetrapyrrole ring of protophyrin IX
Function of Porphyrins
serve as a prosthetic group for
Hemoglobin and myoglobin
Cytochromes in ETC
Cytochrome P450 monooxygenase system
other enzymes
Tissue Locations in Heme biosynthesis
Liver, RBC Precursor Cells
Stages of Heme Biosynthesis
Synthesis of Pyrrole ring
Conversion into Tetrapyrrole
Incorporation of Iron
Stage 1: Synthesis of Pyrrole Ring in the Mitochondria (heme biosynthesis)
Enzyme : Aminolevulinic Acid Synthase (ALAS) makes ALA
PLP is a required coenzyme
Rate-limiting committed step
ALAS1 in the liver is inhibited by excess heme with Fe3+
represses transcription
ALAS2 in erythroid tissues is regulated only by iron availability
Effect of Drugs on ALAS1
Drugs metabolized by microsomal CYP MOA system result in the increase in the activity of ________ enzyme in hepatic tissues.
In response of drugs, CYP protein synthesis increases, leading to enhanced consumptom of heme, leading to increase of ________
X-linked Sideroblastic Anemia
LOF mutatons in ALAS2
Results in reduction in the amount of heme present, preventing erythroid cells from making enough hemoglobin
This causes buildup of excess iron → iron overload
Stage 1: Synthesis of Pyrrole Ring in the Cytosol (heme biosynthesis)
Enzyme: ALA Dehydratase makes Prophobilinogen from ALA
Inhibited by Lead → contributes to the cause of anemia in lead poisoning
Enzyme defect in heme syntehsis before tetrapyrrol ring formation (Stage 2)
Abdominal and Neuropsychiatric signs
Enzyme defect in heme syntehsis after tetrapyrrol ring formation (Stage 2)
Photosensitivity due to the formation of ROS
Stage 3 heme biosynthesis
Enzyme: Ferrochelatase incorportates iron into the tetrapyrrole ring
inhibited by lead
Lead Poisoning
ALA dehydratase and Ferrochelatase are sensitive to inhibition by lead
Protophyrin and ALA accumulate in the urine
ALAD deficiency porphyria is a very rare AR acute hepatic porphyria
NO photosensitivity
Acute Intermittent Porphyria (AIP)
deficiency in hydroxymethylbilane synthase (AD)
Porphobilinogen and ALA accumulate in the urine
urine darkens on exposure to light and air
NO photosensitivity
Congenital Erythropoietic Porphyria (CEP)
Deficiency in uroporphyrinogen III synthase (AR)
Uroporphyrinogen I and coproporphyrinogen I accumulate in the urine
Photosensitivity
Porphyria Cutanea Tarda (PCT)
Deficiency in uroporphyringoen decarboylase (AR)
most common porphyria
Chronic disease of the liver
Clinical onset during the 4th/5th decade of life
Presents with cutaneous symptoms and urine that is red to brown in natural light and pink in fluroescent light
Photosensitivity
Hereditary Coproporphyria (HCP)
deficiency in coproporphyrinogen III oxidase (AD)
coproporphyrinogen III and other precursors accumulate in the urine
Photosensitivity
Variegate Porphyria (VP)
Deficiency in protoporphyrinogen oxidase (AD)
Protoporphyrinogen IX and other intermediates prior to the block accumulate in the urine
photosensitivity
Erthropoietic Protoporphyria (EPP)
Deficiency in Ferrochelatase (can be AR or AD)
Protoporphyrin accumulates in RBCS, bone marrow, and plasma
Photosensitivity
The Acute liver porphyrias
AIP, VP, and HCP
characterized by acute GI attacks, neuropsyh and motor symptoms with photosensitivity
Can be induced by drugs metabolized by the CYP450 system
The Erythropoietic Porphyrias
CEP and EPP
Result in photosensitivity that appear in early childhood
Treatment for Porphyria Attacks
IV injection of hemin and glucose, which ecreases activity of ALAS1
Treatment for photosensitivity caused by Porphyrias
protection, Beta-caretene to scavenge free radicals, phlebotomy
Location of heme breakdown
Macrophages of mononuclear phagocyte system in the liver and spleen
Deficiencies of Bilirubin UDP-gluconosyltransferase
Crigler-Najjar Syndrome Type I and II → most severe (I)
Gilbert Syndrome → often mild and undiagnosed
Symptoms: high levels of Unconjugated bilirubin can be toxic to nervous tissue
Jaundice
Secondary condition caused by deposition of bilirubin
Hemolytic Jaundice
Conditions where hemolytic anemia overwhelms the ability of the liver to conjugate bilirubin → Increased serum UB
Hepatocellular Jaundice
When any liver damage results in defect in conjugation or secretion of bilirubin → increased serum UCB
Obstructive Jaundice
Blocking of the bile duct leads to accumulation of CB in the liver → increased serum CB
Neonatal Jaundice
Transient, physiologic jaundice seen in the first postnatal week → inceased of UB
Treat with phototherapy